REMUUN secures CHF 150’000 to boost precision antibody therapies. https://lnkd.in/dsbSKEC8 Congratulations to amazing team of founders: Richard Chahwan, Paulina Wyrzykowska and Romina Fett. About: REMUUN has created a proprietary, patented MEGA platform that replicates the natural antibody diversification process in a laboratory setting. The platform's modular design allows for rapid and accurate generation of tailored monoclonal antibodies. By building on its expertise in the interactions between immune systems and tumors, REMUUN seeks to deepen scientific understanding and produce more effective immunotherapies. #SwissStartups #VentureKick
